{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:35:53Z","timestamp":1794508553541,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Unrestricted grant from the J. Arch McNamara, MD grant for retinal research at Wills Eye Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objective<\/jats:title>\n                    <jats:p>\n                      Retinal involvement in autoimmune polyendocrine syndrome type 1 (APS1), a rare monogenic autoimmune disorder caused by mutations in the\n                      <jats:italic>AIRE<\/jats:italic>\n                      gene, is increasingly recognised but remains poorly defined. Prior reports suggest a variable phenotype, ranging from mild changes to severe vision loss, often presumed untreatable. We explored the range of retinal phenotypes associated with\n                      <jats:italic>AIRE<\/jats:italic>\n                      gene deficiency in a multicentre case series of patients with APS1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective case note review of patients with molecularly confirmed APS1 from tertiary ophthalmic centres. Clinical history, multimodal retinal imaging, electrophysiology, genetic data, and treatment regimens were analysed. Histopathology was available in one case postmortem.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Records were reviewed from five unrelated female patients. Median age was 14 years at onset of ocular involvement and 33 years at most recent follow up. Some findings from two cases have been previously reported. Three distinct pathogenic\n                      <jats:italic>AIRE<\/jats:italic>\n                      variants contributing to biallelic genotypes were observed. Retinal findings ranged from structurally and functionally normal to advanced degeneration. One patient demonstrated sharp zonal atrophy on histopathology. Inflammatory features predominated in two cases, both showing durable vision preservation with periocular or systemic immunomodulation. One patient demonstrated four years of disease stabilisation with rituximab. No consistent genotype-phenotype correlation emerged.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>AIRE<\/jats:italic>\n                      -associated retinopathy encompasses a diverse spectrum, from clinically silent to profound degeneration. Early, targeted immunomodulation might preserve vision in selected cases. These findings advocate for ophthalmic surveillance in APS1, and support further investigation into predictive biomarkers and possible tailored immunotherapy in this vision-threatening autoimmune disorder.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04365-9","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:19:30Z","timestamp":1775715570000},"page":"1378-1386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retinopathy caused by a primary immune regulatory disorder - the spectrum of AIRE-associated retinopathy: case series and literature review"],"prefix":"10.1038","volume":"40","author":[{"given":"Mohammad","family":"Anas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-8505","authenticated-orcid":false,"given":"Andrew C.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-8396","authenticated-orcid":false,"given":"Siying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-0832","authenticated-orcid":false,"given":"Omar A.","family":"Mahroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-5517","authenticated-orcid":false,"given":"Margaret","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Ralph C.","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-9372","authenticated-orcid":false,"given":"Richard","family":"Vile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Toso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Van Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"crossref","unstructured":"Husebye ES. Autoimmune polyendocrine syndromes. In: The Rose and Mackay Textbook of Autoimmune Diseases, 7th edition, Academic Press,London, UK and Cambridge, MA, USA; 2024. pp. 627\u201339.","DOI":"10.1016\/B978-0-443-23947-2.00044-8"},{"key":"4365_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng1297-393","volume":"17","author":"K Nagamine","year":"1997","unstructured":"Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino, et al. Positional cloning of the APECED gene. Nat Genet. 1997;17:393\u20138.","journal-title":"Nat Genet"},{"key":"4365_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1399-0004.1985.tb02037.x","volume":"27","author":"P Ahonen","year":"1985","unstructured":"Ahonen P. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet. 1985;27:535\u201342.","journal-title":"Clin Genet"},{"key":"4365_CR4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","volume":"322","author":"P Ahonen","year":"1990","unstructured":"Ahonen P, Myll\u00e4rniemi S, Sipil\u00e4 I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829\u201336.","journal-title":"N Engl J Med"},{"key":"4365_CR5","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/bjophthalmol-2014-305897","volume":"99","author":"S Bourgault","year":"2015","unstructured":"Bourgault S, Baril C, Vincent A, H\u00e9on E, Ali A, MacDonald I, et al. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series. Br J Ophthalmol. 2015;99:1536\u201342.","journal-title":"Br J Ophthalmol"},{"key":"4365_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/ICU.0000000000000306","volume":"27","author":"A Couturier","year":"2016","unstructured":"Couturier A, Br\u00e9zin AP. Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1. Curr Opin Ophthalmol. 2016;27:505\u201313.","journal-title":"Curr Opin Ophthalmol"},{"key":"4365_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/09273948.2012.754906","volume":"21","author":"A Breunig","year":"2013","unstructured":"Breunig A, Lee MS, Miller BS, Binstadt BA, Anderson MS, Montezuma S. Autoimmune retinopathy in a patient with autoimmune polyendocrine syndrome type I. Ocul Immunol Inflamm. 2013;21:153\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"4365_CR8","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.1016\/j.ajoc.2022.101266","volume":"25","author":"CJ Culp","year":"2022","unstructured":"Culp CJ, Pappas CM, Toso M, Qu P, Mamalis N, Hageman GS. Clinical, histological and genetic findings in a donor with a clinical history of type 1 autoimmune polyendocrinopathy syndrome. Am J Ophthalmol Case Rep. 2022;25:101266.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"4365_CR9","doi-asserted-by":"publisher","first-page":"p.e252672","DOI":"10.1136\/bcr-2022-252672","volume":"16","author":"A Bari","year":"2023","unstructured":"Bari A, Mahmood A, Chawla R, Sinha R. Ocular features of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. BMJ Case Rep CP. 2023;16:p.e252672.","journal-title":"BMJ Case Rep CP"},{"key":"4365_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10633-023-09953-8","volume":"147","author":"X Wei","year":"2023","unstructured":"Wei X, Zhu T, Wang L, Sui R. Leber congenital amaurosis as the initial and essential manifestation in a Chinese patient with autoimmune polyglandular syndrome Type 1. Doc Ophthalmol. 2023;147:225\u201332.","journal-title":"Doc Ophthalmol"},{"key":"4365_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6","volume":"13","author":"M Heino","year":"1999","unstructured":"Heino M, Scott HS, Chen Q, Peterson P, M\u00e4enp\u00e4\u00e4 U, Papasavvas MP, et al. Mutation analyses of North American APS-1 patients. Hum Mutat. 1999;13:69\u201374.","journal-title":"Hum Mutat"},{"key":"4365_CR12","doi-asserted-by":"publisher","first-page":"a002485","DOI":"10.1101\/mcs.a002485","volume":"4","author":"E Sanford","year":"2018","unstructured":"Sanford E, Watkins K, Nahas S, Gottschalk M, Coufal NG, Farnaes L, et al. Rapid whole-genome sequencing identifies a novel AIRE variant associated with autoimmune polyendocrine syndrome type 1. Mol Case Stud. 2018;4:a002485.","journal-title":"Mol Case Stud"},{"key":"4365_CR13","doi-asserted-by":"crossref","unstructured":"100,000 Genomes Project Pilot Investigators, 2021. 100,000 genomes pilot on rare-disease diagnosis in health care\u2014preliminary report. N Engl J Med. 2021;385:1868\u201380.","DOI":"10.1056\/NEJMoa2035790"},{"key":"4365_CR14","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1167\/iovs.02-1278","volume":"44","author":"AG Robson","year":"2003","unstructured":"Robson AG, El-Amir A, Bailey C, Egan CA, Fitzke FW, Webster AR, et al. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003;44:3544\u201350. https:\/\/doi.org\/10.1167\/iovs.02-1278.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4365_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/09273948.2023.2208212","volume":"32","author":"LM Hassan","year":"2024","unstructured":"Hassan LM, Hassan MM, Abou Shady H, Khedr D. VKH with APECED in a two-year-old child: a rare concomitant diagnosis in an unprecedented age. Ocul Immunol Inflamm. 2024;32:433\u20136.","journal-title":"Ocul Immunol Inflamm"},{"key":"4365_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/pgmj.72.850.495","volume":"72","author":"NS Jovic","year":"1996","unstructured":"Jovic NS, Nesovic M, Vranjesevic DN, Ciric J, Marinkovic DM, Bonaci B. The Vogt-Koyanagi-Harada syndrome: association with autoimmune polyglandular syndrome type 1. Postgrad Med J. 1996;72:495\u20137.","journal-title":"Postgrad Med J"},{"key":"4365_CR17","doi-asserted-by":"publisher","first-page":"687280","DOI":"10.3389\/fimmu.2021.687280","volume":"12","author":"H Sakaguchi","year":"2021","unstructured":"Sakaguchi H, Mizuochi T, Haruta M, Takase R, Yoshida S, Yamashita Y, et al. AIRE gene mutation presenting at age 2 years with autoimmune retinopathy and steroid-responsive acute liver failure: a case report and literature review. Front Immunol. 2021;12:687280.","journal-title":"Front Immunol"},{"key":"4365_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38419-9","volume":"13","author":"A Badawi","year":"2023","unstructured":"Badawi A, Magliyah M, Alabbasi O, AlAbdi L, Alkuraya FS, Schatz, et al. Cone dystrophy associated with autoimmune polyglandular syndrome type 1. Sci Rep. 2023;13:11223.","journal-title":"Sci Rep"},{"key":"4365_CR19","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1084\/jem.20061864","volume":"203","author":"J DeVoss","year":"2006","unstructured":"DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med. 2006;203:2727\u201335.","journal-title":"J Exp Med"},{"key":"4365_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamaophthalmol.2021.0651","volume":"139","author":"JJ Chen","year":"2021","unstructured":"Chen JJ, McKeon A, Greenwood TM, Flanagan EP, Bhatti MT, Dubey D, et al. Clinical utility of antiretinal antibody testing. JAMA Ophthalmol. 2021;139:658\u201362. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.0651.","journal-title":"JAMA Ophthalmol"},{"key":"4365_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archopht.1991.01080080023012","volume":"109","author":"LW Wood","year":"1991","unstructured":"Wood LW, Jampol LM, Daily MJ. Retinal and optic nerve manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Arch Ophthalmol. 1991;109:1065.","journal-title":"Arch Ophthalmol"},{"key":"4365_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01933-y","volume":"16","author":"YB Wang","year":"2021","unstructured":"Wang YB, Wang O, Nie M, Jiang Y, Li M, Xia WB, et al. Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series. Orphanet J rare Dis. 2021;16:1\u20138.","journal-title":"Orphanet J rare Dis"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04365-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:54:21Z","timestamp":1781510061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04365-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GSH is a shareholder, consultant and co-founder of Perceive Biotherapeutics, Inc. and an inventor on patents and patent applications owned by the University of Utah. None of the other authors has any relevant proprietary interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}